Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jun 6;17(1):1853–1858. doi: 10.1016/j.sapharm.2020.06.005

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Elsevier Inc. All rights reserved.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig. 2 — Characteristics of medication recommendations for different drugs. A: Classification and cause of recommendations for different drugs. B: Adverse drug event-related recommendations for different drugs. C: Treatment effectiveness related-recommendations for antibiotics and antifungal drugs. D: Therapy adjustment recommendations for antibiotics and antifungal drugs after identifying adverse drug events. E: Adverse drug event related-recommendations for different antiviral agents. F: Therapy adjustment recommendations for antiviral agents after identifying adverse drug events. P1: treatment effectiveness; P2: adverse drug event occurring; CVS: cardiovascular system; GI: gastrointestinal; Dar/C: darunavir/cobicistat; Lop/r, lopinavir/ritonavir.